Reuters reported quoting the global health agency's spokesperson. The spokesperson further added he expects WHO recommendation on use of Covaxin within next 24 hours. "If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a UN press briefing.
The WHO had earlier emphasized that it must evaluate a vaccine thoroughly to make sure it is "safe and effective". Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use Listing (EUL).